Cullinan Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Hold |
12,600
| – | – | 0.07% | 128 |
|
|
2025
Q1 | $913K | Hold |
12,600
| – | – | 0.06% | 131 |
|
|
2024
Q4 | $933K | Sell |
12,600
-1,311
| -9% | -$97.1K | 0.06% | 137 |
|
|
2024
Q3 | $973K | Hold |
13,911
| – | – | 0.05% | 143 |
|
|
2024
Q2 | $1.28M | Hold |
13,911
| – | – | 0.07% | 132 |
|
|
2024
Q1 | $1.33M | Buy |
13,911
+1,100
| +9% | +$105K | 0.07% | 136 |
|
|
2023
Q4 | $977K | Hold |
12,811
| – | – | 0.05% | 145 |
|
|
2023
Q3 | $888K | Hold |
12,811
| – | – | 0.05% | 149 |
|
|
2023
Q2 | $1.21M | Hold |
12,811
| – | – | 0.07% | 147 |
|
|
2023
Q1 | $1.06M | Hold |
12,811
| – | – | 0.06% | 155 |
|
|
2022
Q4 | $956K | Hold |
12,811
| – | – | 0.05% | 163 |
|
|
2022
Q3 | $1.06M | Hold |
12,811
| – | – | 0.07% | 140 |
|
|
2022
Q2 | $1.22M | Buy |
12,811
+6,300
| +97% | +$599K | 0.07% | 132 |
|
|
2022
Q1 | $766K | Hold |
6,511
| – | – | 0.04% | 157 |
|
|
2021
Q4 | $844K | Hold |
6,511
| – | – | 0.04% | 149 |
|
|
2021
Q3 | $737K | Hold |
6,511
| – | – | 0.04% | 158 |
|
|
2021
Q2 | $674K | Buy |
6,511
+1,311
| +25% | +$136K | 0.04% | 153 |
|
|
2021
Q1 | $435K | Hold |
5,200
| – | – | 0.03% | 166 |
|
|
2020
Q4 | $474K | Buy |
+5,200
| New | +$474K | 0.03% | 148 |
|